台華新材(603055.SH):創友投資質押1.215億股
格隆匯11月6日丨台華新材(603055.SH)公佈,公司收到股東創友投資通知,創友投資於近日將其所持公司1.215億股無限售流通股質押給光大證券辦理股票質押式回購交易業務,並已在中國登記結算有限責任公司上海分公司辦理了股份質押登記手續。
截至公告披露日,創友投資持有公司股份數量為1.74億股,全部為無限售條件的流通股,佔公司總股本比例為22.44%。本次股份質押後,創友投資累計質押數量為1.22億股,佔其持有公司股份數的69.93%,佔公司總股本的15.69%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.